Charlie Dent

Congressman Charlie Dent currently serves as a Senior Policy Advisor to DLA Piper where he provides strategic advice and counsel to clients on the federal, state and local levels on issues ranging from appropriations, healthcare, defense and veterans, homeland security, infrastructure and energy to international investment, trade and commerce. In addition to his role with DLA Piper, Congressman Dent is a Political Analyst for CNN, a Visiting Fellow for the University of Pennsylvania (UPENN), Perry World House and a Distinguished Advisor for Pew Charitable Trusts.

Prior to those positions, Congressman Dent served 7 terms in the U.S. House of Representatives representing the 15th Congressional District of Pennsylvania. During his time in Congress, Congressman Dent distinguished himself as a strong, independent leader who is well respected on both sides of the aisle. Congressman Dent was a senior member of the House Appropriations Committee where he chaired the Subcommittee on Military Construction, Veterans Affairs and Related Agencies. Additionally, he served as the Chairman of the House Committee on Ethics from 2015 – 2017. In addition to his role as a senior Appropriator, Congressman Dent was the co-chair of the Tuesday Group, a caucus of more than 50 center-right Republicans, where he played an important role in many of the most challenging policy and political issues confronted by Congress. Congressman Dent was a member of the Speaker of the House’s weekly cross section lunch and was a member of the Majority Leader’s Chairman’s Table.

Before his time in the U.S. House of Representatives, Congressman Dent served for 6 years in the Pennsylvania State Senate and 8 years in the Pennsylvania General Assembly.

Congressman Dent holds a Bachelor of Arts in Foreign Service and International Politics from the Pennsylvania State University and a Master of Public Administration from Lehigh University. In 2015, Moravian College conferred the honorary degree of Doctor of Laws upon Congressman Dent. He joined CARE’s Board in 2020.